ES544341A0 - Procedimiento para la obtencion de heteroariloxiacetamidas - Google Patents

Procedimiento para la obtencion de heteroariloxiacetamidas

Info

Publication number
ES544341A0
ES544341A0 ES544341A ES544341A ES544341A0 ES 544341 A0 ES544341 A0 ES 544341A0 ES 544341 A ES544341 A ES 544341A ES 544341 A ES544341 A ES 544341A ES 544341 A0 ES544341 A0 ES 544341A0
Authority
ES
Spain
Prior art keywords
heteroariloxiacetamidas
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES544341A
Other languages
English (en)
Other versions
ES8604542A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES544341A0 publication Critical patent/ES544341A0/es
Publication of ES8604542A1 publication Critical patent/ES8604542A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/071,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/13Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
ES544341A 1984-06-20 1985-06-19 Procedimiento para la obtencion de heteroariloxiacetamidas Expired ES8604542A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843422861 DE3422861A1 (de) 1984-06-20 1984-06-20 Verfahren zur herstellung von heteroaryloxyacetamiden

Publications (2)

Publication Number Publication Date
ES544341A0 true ES544341A0 (es) 1986-02-01
ES8604542A1 ES8604542A1 (es) 1986-02-01

Family

ID=6238800

Family Applications (1)

Application Number Title Priority Date Filing Date
ES544341A Expired ES8604542A1 (es) 1984-06-20 1985-06-19 Procedimiento para la obtencion de heteroariloxiacetamidas

Country Status (7)

Country Link
US (1) US5101034A (es)
EP (1) EP0165537B1 (es)
JP (1) JPH0714925B2 (es)
KR (1) KR920010393B1 (es)
DE (2) DE3422861A1 (es)
ES (1) ES8604542A1 (es)
IL (1) IL75533A (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505902A1 (de) * 1985-02-21 1986-08-21 Bayer Ag, 5090 Leverkusen 4,5-disubstituierte 1,3-thiazol-2-yloxyacetamide
DE3724467A1 (de) * 1987-07-24 1989-02-02 Bayer Ag 6-chlorbenzoxazolyl-oxyacetanilide
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
DE3821600A1 (de) 1988-06-27 1989-12-28 Bayer Ag Heteroaryloxyessigsaeure-n-isopropylanilide
DE4003436A1 (de) * 1990-02-06 1991-08-08 Bayer Ag Verfahren zur herstellung von 2-alkylthio-1,3,4-thiadiazolen
DE4133673A1 (de) * 1991-10-11 1993-04-15 Bayer Ag Neue 2- (2-benzoxazolyl-oxy)-acetamide
DE4225024A1 (de) 1992-07-29 1994-02-03 Bayer Ag Chlorthiazolderivate
US5547967A (en) * 1993-12-08 1996-08-20 Kali-Chemie Pharma Gmbh (Phenylalkylaminoalkyloxy)-heteroaryl-compounds, processes and intermediates for their production and pharmaceutical compositions containing them
DE19530767A1 (de) * 1995-08-22 1997-02-27 Bayer Ag N-(1-Isopropyl-2-methyl-1-propenyl) -heteroaryloxyacetamide
ID26178A (id) * 1997-11-18 2000-12-07 American Cyanamid Co N-alkenil heteroarililoksiasetamida pembasmi hama atau gulma
US5905157A (en) * 1997-12-12 1999-05-18 Bayer Corporation Process for producing 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithiocarbazinate and trifluoroacetic acid
US5895818A (en) * 1997-12-12 1999-04-20 Bayer Corporation Process for making N-(4-fluorophenyl)-N-(1-methylethyl)-2- (5-trifuloromethyl)-1,3,4-thiadiazol-2-yl)oxy!acetamide using an aprotic, aromatic solvent
US5792872A (en) * 1997-12-12 1998-08-11 Bayer Corporation Process for producing N-(4-fluorophenyl)-N-(1-methylethyl)-2- (5-trifluoromethyl-1,3,4-thiadiazol-2-yl)oxy!acetamide
CA2254579C (en) * 1997-12-12 2007-10-30 Bayer Corporation Synthesis of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole via oxidation of 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole with a molybdenum or tungsten catalyst
US5808153A (en) * 1997-12-12 1998-09-15 Prasad; Vidyanatha A. Conversion of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide acetate to N-4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide
US5898074A (en) * 1997-12-12 1999-04-27 Bayer Corporation Process for preparing 2-(methylthio)-5-(trifluoromethyl) -1,3,4-thiadiazole using methyldithiocarbazinate and a molar excess of trifluoroacetic acid with recovery of trifluoroacetic acid
US5852202A (en) * 1997-12-12 1998-12-22 Bayer Corporation Process for isolating N-(4-fluorophenyl)-N-(1-methylethyl)-2- (5-trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy!acetamide
US6005114A (en) * 1997-12-12 1999-12-21 Bayer Corporation Process for making 2-(methylthio)-5(trifluoromethyl)-1,3,4,-thiadiazole using methyldithiocarbazinate with trifluoroacetic acid with selective removal of 2,5-bis(methylthio)-1,3,4-thiadiazole
US6031108A (en) * 1998-09-16 2000-02-29 Bayer Corporation Process for the preparation of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole (TDA sulfone)
DE19935964A1 (de) 1999-07-30 2001-02-01 Bayer Ag 5-Chlordifluormethyl-1,3,4-thiadiazol-2-yl-oxyacetanilide
US6339042B1 (en) 1999-11-29 2002-01-15 American Cyanamid Co. Herbicidal N-cyclohexadienyl heteroaryloxyacetamides
JP4513251B2 (ja) * 2002-10-11 2010-07-28 住友化学株式会社 チアジアゾール化合物およびその用途
US8916550B2 (en) * 2005-05-09 2014-12-23 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
EP1888575A2 (en) * 2005-05-09 2008-02-20 Hydra Biosciences, Inc. Compounds for modulating trpv3 function
WO2008033564A1 (en) 2006-09-15 2008-03-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
CN106478547B (zh) * 2016-08-30 2019-02-01 京博农化科技股份有限公司 一种2-甲砜基-5-三氟甲基-1,3,4-噻二唑的合成方法
CA3168103A1 (en) 2020-01-29 2021-08-05 Kamari Pharma Ltd. Compounds and compositions for use in treating skin disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005501B1 (de) * 1978-05-20 1981-11-25 Bayer Ag Heteroaryl-oxyessigsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide
EP0018497B1 (de) * 1979-04-06 1982-04-28 Bayer Ag Azolyloxy-essigsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide
US4364769A (en) * 1979-07-13 1982-12-21 Ciba-Geigy Corporation 1,3,4-Thiadiazolyloxyphenylureas
DE2946524A1 (de) * 1979-11-17 1981-06-11 Bayer Ag, 5090 Leverkusen Azolyloxy-carbonsaeure-n-oxy-amide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
DE3027483A1 (de) * 1980-07-19 1982-02-25 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung heterocyclisch substituierter 4-oxiphenoxialkancarbonsaeurederivate
DE3038636A1 (de) * 1980-10-13 1982-05-27 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von substituierten oxyessigsaeureamiden
DE3148839A1 (de) * 1981-12-10 1983-06-23 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von hetaryloxyacetamiden
DE3400168A1 (de) * 1984-01-04 1985-07-11 Bayer Ag, 5090 Leverkusen 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide
DE3418168A1 (de) * 1984-05-16 1985-11-21 Bayer Ag, 5090 Leverkusen 6-chlorbenzazolyloxyacetamide

Also Published As

Publication number Publication date
JPH0714925B2 (ja) 1995-02-22
KR920010393B1 (ko) 1992-11-27
DE3422861A1 (de) 1986-01-02
IL75533A (en) 1990-01-18
JPS6117575A (ja) 1986-01-25
EP0165537B1 (de) 1990-01-17
DE3575423D1 (de) 1990-02-22
EP0165537A2 (de) 1985-12-27
EP0165537A3 (en) 1987-03-04
ES8604542A1 (es) 1986-02-01
US5101034A (en) 1992-03-31
IL75533A0 (en) 1985-10-31
KR860000272A (ko) 1986-01-27

Similar Documents

Publication Publication Date Title
ES555050A0 (es) Procedimiento para la obtencion de aril-ciclopropil-oxiranos
ES539781A0 (es) Procedimiento para la obtencion de 5-amino-fenil-pirazoles sustituidos
ES547951A0 (es) Procedimiento para la preparacion de nuevas benzoilfenilu- reas
ES548798A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4- hidroxivalerilo
ES544341A0 (es) Procedimiento para la obtencion de heteroariloxiacetamidas
ES546360A0 (es) Procedimiento para la obtencion de poli-hidro piridazo dia- cepinas triacepinas o diazocinas
ES554488A0 (es) Procedimiento para la obtencion de compuestos carbonilicos
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES547924A0 (es) Procedimiento para la preparacion de bencileteres sustitui- dos
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
MX162421A (es) Procedimiento para la preparacion de n-acilfenilalaninas
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES541906A0 (es) Procedimiento para la preparacion de glicidiloxidicetonas
ES542071A0 (es) Procedimiento para la preparacion de ergolinas
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES543832A0 (es) Procedimiento para la obtencion de fenilsulfonilureas susti-tuidas
ES541265A0 (es) Procedimiento para la obtencion de derivados de tiocianopi- rimidina
ES531159A0 (es) Procedimiento para la preparacion de aminociclotiadiazinas
ES546681A0 (es) Procedimiento para la obtencion de fenilsulfonilazoles sus- tituidos
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES554606A0 (es) Procedimiento para la obtencion de piridiletil-dihidropiridinas
ES546557A0 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041113